Torchmark Corp. (TMK) Falls 2.86% for December 21

Equities Staff  |

One of the S&P 500’s big losers for Monday December 21 was Torchmark Corp. (TMK). The company’s stock fell 2.86% to $55.36 on volume of 1.38 million shares.

The stock opened the day at 56.63 and traded between a low of $55.35 and a high of $56.66. The stock finished the day down $1.63 per share. Torchmark Corp. has an average daily volume of 725,988 and a total float of 123.33 million shares. The 50-day SMA for Torchmark Corp. is $58.98 and its 200-day SMA is $57.91. The high for the stock over the last 52 weeks is $63.26 and the low is $49.77.

Torchmark Corp is an insurance holding company. It markets individual life and supplemental health insurance and to limited extent annuities, to middle income households throughout the United States.

Torchmark Corp. is centered in McKinney, TX, and has 2,980 employees. Today’s trading day leaves the company with a market cap of $6.83 billionwith a P/E Ratio of 13.1. The company has a P/S ratio of 1.73, P/B ratio of 1.59, and a 8.5.

For a complete fundamental analysis analysis of Torchmark Corp., check out’s Stock Valuation Analysis report for TMK. To see the latest independent stock recommendations from’s analysts, visit our Research section.

The S&P 500 represents the industry standard for large-cap indices. While the Dow Jones Industrial Average (DJIA) may be the most visible stock market index in the country, the S&P 500 has long been relied on by industry insiders and fund managers as the more reliable gauge of portfolio performance.

While the DJIA is price-weighted and only includes 30 stocks, the S&P 500 uses a weighting system that factors in market cap and the size of a company’s free float while including some 500 stocks for a more comprehensive look at the broader markets’ performance. Its performance is far more representative of the large- and mega-cap stocks for any period of time.

For more news on the financial markets, go to Also, learn more about our independent proprietary equity research reports and our robust do-it-yourself Stock Valuation Analysis reports in our Research section.

All data provided by QuoteMedia and was accurate as of 4:30PM ET.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to:



Symbol Last Price Change % Change










Q BioMed CEO provides a Corporate Update

Denis Corin, CEO of Q BioMed Inc. ”Q“, a biomedical acceleration and development company, focused on licensing and acquiring undervalued biomedical assets in the healthcare sector, provides a corporate update.

Emerging Growth

Permanent Techs Inc

Permanent Technologies Inc engages in the design and manufacture of multi-faceted, vibration-proof, self-locking nut and bolt systems for use in the fastener industry in the United States. The Company also…